<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0089">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>L.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lin</surname>
    <given-names>D.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sun</surname>
    <given-names>X.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Curth</surname>
    <given-names>U.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Drosten</surname>
    <given-names>C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sauerhering</surname>
    <given-names>L.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Becker</surname>
    <given-names>S.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rox</surname>
    <given-names>K.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Hilgenfeld</surname>
    <given-names>R.</given-names>
   </name>
  </person-group> (
  <year>2020b</year>). 
  <article-title>Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors</article-title>. 
  <source>
   <italic>Science (New York, NY.)</italic>
  </source>, 
  <volume>368</volume>(
  <issue>6489</issue>), 
  <fpage>409</fpage>–
  <lpage>412</lpage>. 
  <pub-id pub-id-type="doi">10.1126/science.abb3405</pub-id>
 </mixed-citation>
</ref>
